Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 69876 - 69900 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Silicon dioxide	Approved	CDK18	5129	downregulated	Silicon Dioxide analog results in decreased expression of CDK18 mRNA	1q32.1	A24195
Silicon dioxide	Approved	CDK19	23097	downregulated	Silicon Dioxide results in decreased expression of CDK19 mRNA	6q21	A24196
Silicon dioxide	Approved	CDK5RAP3	80279	downregulated	Silicon Dioxide results in decreased expression of CDK5RAP3 mRNA	17q21.32	A24196
Silicon dioxide	Approved	CDKN1A	1026	upregulated	Silicon Dioxide analog results in increased expression of CDKN1A mRNA	6p21.2	A24194 A24195
Silicon dioxide	Approved	CDKN1C	1028	downregulated	Silicon Dioxide analog results in decreased expression of CDKN1C mRNA	11p15.4	A24195
Silicon dioxide	Approved	CDKN1C	1028	upregulated	Silicon Dioxide results in increased expression of CDKN1C mRNA	11p15.4	A24196
Silicon dioxide	Approved	CDKN3	1033	downregulated	Silicon Dioxide analog results in decreased expression of CDKN3 mRNA	14q22.2	A24195
Silicon dioxide	Approved	CDKN3	1033	upregulated	Silicon Dioxide results in increased expression of CDKN3 mRNA	14q22.2	A24196
Silicon dioxide	Approved	CDNF	441549	downregulated	Silicon Dioxide analog results in decreased expression of CDNF mRNA	10p13	A24195
Silicon dioxide	Approved	CDRT1	374286	upregulated	Silicon Dioxide analog results in increased expression of CDRT1 mRNA	17p12	A24195
Silicon dioxide	Approved	CDS1	1040	downregulated	Silicon Dioxide analog results in decreased expression of CDS1 mRNA	4q21.23	A24195
Silicon dioxide	Approved	CEACAM1	634	downregulated	Silicon Dioxide analog results in decreased expression of CEACAM1 mRNA	19q13.2	A24195
Silicon dioxide	Approved	CEACAM1	634	upregulated	Silicon Dioxide results in increased expression of CEACAM1 mRNA	19q13.2	A24197
Silicon dioxide	Approved	CEACAM3	1084	downregulated	Silicon Dioxide analog results in decreased expression of CEACAM3 mRNA	19q13.2	A24195
Silicon dioxide	Approved	CEACAM5	1048	downregulated	Silicon Dioxide analog results in decreased expression of CEACAM5 mRNA	19q13.2	A24195
Silicon dioxide	Approved	CEACAM5	1048	downregulated	Silicon Dioxide results in decreased expression of CEACAM5 mRNA	19q13.2	A24196
Silicon dioxide	Approved	CEACAM6	4680	downregulated	Silicon Dioxide analog results in decreased expression of CEACAM6 mRNA	19q13.2	A24195
Silicon dioxide	Approved	CEACAM7	1087	downregulated	Silicon Dioxide analog results in decreased expression of CEACAM7 mRNA	19q13.2	A24195
Silicon dioxide	Approved	CEBPA	1050	downregulated	Silicon Dioxide analog results in decreased expression of CEBPA mRNA	19q13.11	A24195
Silicon dioxide	Approved	CEBPA	1050	upregulated	Silicon Dioxide analog results in increased expression of CEBPA mRNA	19q13.11	A24194
Silicon dioxide	Approved	CEBPA	1050	downregulated	Silicon Dioxide results in decreased expression of CEBPA mRNA	19q13.11	A24196
Silicon dioxide	Approved	CEBPA-AS1	80054	downregulated	Silicon Dioxide results in decreased expression of CEBPA-AS1 mRNA	19q13.11	A24196
Silicon dioxide	Approved	CEBPB	1051	upregulated	Silicon Dioxide analog results in increased expression of CEBPB mRNA	20q13.13	A24195
Silicon dioxide	Approved	CEBPB	1051	upregulated	Silicon Dioxide results in increased expression of CEBPB mRNA	20q13.13	A24203
Silicon dioxide	Approved	CELF5	60680	downregulated	Silicon Dioxide analog results in decreased expression of CELF5 mRNA	19p13.3	A24195

Displaying entries 69876 - 69900 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability